Issue Information
Cancer, Volume 124, Issue 19, Page 3787-3794, October 1, 2018. (Source: Cancer)
Source: Cancer - November 9, 2018 Category: Cancer & Oncology Tags: Issue Information Source Type: research
Klinefelter syndrome in males with germ cell tumors: A report from the Children's Oncology Group
CONCLUSIONSCompared with males without chromosomal abnormalities, males with KS are more likely to be diagnosed with a mediastinal GCT. The presence of KS should be considered in males with a diagnosis of mediastinal GCT. In the current study, the authors report that approximately one ‐third of males with mediastinal germ cell tumors have Klinefelter syndrome, and therefore screening of these individuals for the syndrome may be warranted. Males with Klinefelter syndrome are 19 times as likely as males without Klinefelter syndrome to develop germ cell tumors. (Source: Cancer)
Source: Cancer - November 9, 2018 Category: Cancer & Oncology Authors: Lindsay A. Williams,
Nathan Pankratz,
John Lane,
Mark Krailo,
Michelle Roesler,
Michaela Richardson,
A. Lindsay Frazier,
James F. Amatruda,
Jenny N. Poynter Tags: Original Article Source Type: research
New drug option for men with aggressive prostate cancer
Cancer, Volume 124, Issue 19, Page 3797-3797, October 1, 2018. (Source: Cancer)
Source: Cancer - November 9, 2018 Category: Cancer & Oncology Authors: Carrie Printz Tags: CancerScope Source Type: research
High ‐nicotine dependent smokers less likely to quit after screening
Cancer, Volume 124, Issue 19, Page 3797-3797, October 1, 2018. (Source: Cancer)
Source: Cancer - November 9, 2018 Category: Cancer & Oncology Authors: Carrie Printz Tags: CancerScope Source Type: research
First person: Arlene Sharpe, MD, PhD
Cancer, Volume 124, Issue 19, Page 3795-3796, October 1, 2018. (Source: Cancer)
Source: Cancer - November 9, 2018 Category: Cancer & Oncology Authors: Carrie Printz Tags: CancerScope Source Type: research
The association between medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening
ConclusionsSmall ‐magnitude reductions were observed in breast and prostate cancer screening rates, and a small increase was observed in colorectal cancer screening associated with ACO enrollment. Although ACO enrollment does not appear to drive wholesale changes in cancer screening, small differences may map to m eaningful changes in the epidemiology of screen‐detected cancers among Medicare beneficiaries. (Source: Cancer)
Source: Cancer - November 9, 2018 Category: Cancer & Oncology Authors: Matthew J. Resnick,
Amy J. Graves,
Robert J. Gambrel,
Sunita Thapa,
Melinda B. Buntin,
David F. Penson Tags: Original Article Source Type: research
The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening
ConclusionsAlthough all patients with breast cancer stand to benefit from advances in breast cancer therapy, the current results demonstrate that women who have participated in mammography screening obtain a significantly greater benefit from the therapy available at the time of diagnosis than do those who have not participated. (Source: Cancer)
Source: Cancer - November 8, 2018 Category: Cancer & Oncology Authors: L ászló Tabár,
Peter B. Dean,
Tony Hsiu‐Hsi Chen,
Amy Ming‐Fang Yen,
Sam Li‐Sheng Chen,
Jean Ching‐Yuan Fann,
Sherry Yueh‐Hsia Chiu,
May Mei‐Sheng Ku,
Wendy Yi‐Ying Wu,
Chen‐Yang Hsu,
Yu‐Ching Chen,
Kerri Beckmann,
Robert Tags: Original Article Source Type: research
Pregnancy after cancer: Timing is everything
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 7, 2018 Category: Cancer & Oncology Authors: Ann H. Partridge Tags: Editorial Source Type: research
Pregnancy after cancer: Does timing of conception affect infant health?
ConclusionsIn women who received chemotherapy, the higher risk of preterm birth was limited to those survivors who had short intervals between treatment and conception.Cancer 2018;0:1 ‐7. (Source: Cancer)
Source: Cancer - November 7, 2018 Category: Cancer & Oncology Authors: Kathleen P. Hartnett,
Ann C. Mertens,
Michael R. Kramer,
Timothy L. Lash,
Jessica B. Spencer,
Kevin C. Ward,
Penelope P. Howards Tags: Original Article Source Type: research
Pregnancy after cancer: Timing is everything
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 7, 2018 Category: Cancer & Oncology Authors: Ann H. Partridge Tags: Editorial Source Type: research
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children ’s Oncology Group Phase 1 and Pilot Consortium Trial (ADVL1315)
ConclusionsIn children with refractory solid tumors, the maximum tolerated and recommended dose of axitinib appears to be 2.4 mg/m2/dose, which provides PK exposures similar to those of adults. (Source: Cancer)
Source: Cancer - November 5, 2018 Category: Cancer & Oncology Authors: James I. Geller,
Elizabeth Fox,
Brian K. Turpin,
Stuart L. Goldstein,
Xiaowei Liu,
Charles G. Minard,
Rachel A. Kudgus,
Joel M. Reid,
Stacey L. Berg,
Brenda J. Weigel Tags: Original Article Source Type: research
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma
ConclusionsThe current findings are consistent with previously reported trials and confirm the safety profile of daratumumab in heavily pretreated US patients who have relapsed or refractory MM.Cancer 2018;124:000 ‐000. (Source: Cancer)
Source: Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Ajai Chari,
Sagar Lonial,
Tomer M. Mark,
Amrita Y. Krishnan,
Keith E. Stockerl ‐Goldstein,
Saad Z. Usmani,
Anil Londhe,
Delores Etheredge,
Sarah Fleming,
Baolian Liu,
Jon Ukropec,
Thomas S. Lin,
Sundar Jagannath,
Ajay K. Nooka Tags: Original Article Source Type: research
Erratum
Cancer, EarlyView. (Source: Cancer)
Source: Cancer - November 5, 2018 Category: Cancer & Oncology Tags: Erratum Source Type: research
